Hormone Therapy-Breast Cancer Tie Grows
Five Years Of Still-Popular Postmenopause Hormone Treatment Doubles Breast Cancer Risk
-
A new analysis finds that postmenopausal hormone therapy - a long popular treatment for unpleastant symtoms - seriously increases the risk of breast cancer. Doctors say that in most cases the risks of hormone use far outweight the benefits. (CBS/AP)
-
Play CBS Video Video New Risks With HRT Maggie Rodriguez speaks with Dr. Elisa Port about new research that shows how hormone replacement therapy can make breast cancer more difficult to detect.
-
Video Breast Cancer Numbers Plummet Since 2002, when millions of menopausal women stopped talking hormone replacement therapy, the rate of breast cancer dropped significantly. Dr. Jon LaPook reports.
-
Video Synthetic Hormones & Cancer Dr. Emily Senay speaks with Russ Mitchell about evidence from a new study, showing a link between hormone replacement therapy and breast cancer.
-
Photo Essay In The Pink October, breast cancer awareness month, goes way beyond the ribbons.
Even women who took estrogen and progestin pills for as little as a couple of years had a greater chance of getting cancer. And when they stopped taking them, their odds quickly improved, returning to a normal risk level roughly two years after quitting.
Collectively, these new findings are likely to end any doubt that the risks outweigh the benefits for most women.
It is clear that breast cancer rates plunged in recent years mainly because millions of women quit hormone therapy and fewer newly menopausal women started on it, said the study's leader, Dr. Rowan Chlebowski of Harbor-UCLA Medical Center in Los Angeles.
"It's an excellent message for women: You can still diminish risk (by quitting), even if you've been on hormones for a long time," said Dr. Claudine Isaacs of Georgetown University's Lombardi Comprehensive Cancer Center. "It's not like smoking where you have to wait 10 or 15 years for the risk to come down."
Study results were given Saturday at the San Antonio Breast Cancer Symposium.
They are from the Women's Health Initiative, which tested estrogen and progestin pills that doctors long believed would prevent heart disease, bone loss and many other problems in women after menopause. The main part of the study was stopped in 2002 when researchers saw surprisingly higher risks of heart problems and breast cancer in hormone users.
Since then, experts have debated whether these risks apply to women who start on hormones when they enter menopause, usually in their 50s, and take them for shorter periods of time. Most of the women in the federal study were in their 60s and well past menopause.
So the advice has been to use hormones only if symptoms like hot flashes are severe, and at the lowest dose and shortest time possible. The new study sharpens that message, Chlebowski said.
"It does change the balance" on whether to start on treatment at all, he said.
Even so, most women will not get breast cancer by taking the pills short-term. The increased cancer risk from a couple of years of hormone use translates to a few extra cases of breast cancer a year for every 1,000 women on hormones. This risk accumulates with each year of use, though.
The Women's Health Initiative study had two parts. In one, 16,608 women closely matched for age, weight and other health factors were randomly assigned to take either Wyeth Pharmaceuticals' Prempro - estrogen and progestin - or dummy pills.
See the findings of the Women's Health Initiative study on postmenopausal hormone use.
This part was halted when researchers saw a 26 percent higher risk of breast cancer in those on Prempro.
But that was an average over the 5½ years women were on the pills. For the new study, researchers tracked 15,387 of these women through July 2005, and plotted breast cancer cases as they occurred over time.
They saw a clear trend: Risk rose with the start of use, peaked when the study ended and fell as nearly all hormone users stopped taking their pills. At the peak, the breast cancer risk for pill takers was twice that of the others.
Think of it as President George W. Bush's public approval rating, said another study leader, Dr. Peter Ravdin of the University of Texas M.D. Anderson Cancer Center in Houston.
"Bush's popularity may be 50 percent on average, but it might have been descending the whole time he was president," Ravdin said.
It is clear that breast cancer rates plunged in recent years mainly because millions of women quit hormone therapy and fewer newly menopausal women started on it, said the study's leader, Dr. Rowan Chlebowski of Harbor-UCLA Medical Center.
Plotting cases over time, researchers saw in retrospect that hormone users had started out with twice the risk of breast cancer as the others, and it fell as use declined. Among those taking hormones at the start of the study, use dropped to 41 percent in 2003, the year after the main results made news.
In the general population, use of hormone products has dropped 70 percent since the study, said another of its leaders, Dr. JoAnn Manson, preventive medicine chief at Harvard's Brigham and Women's Hospital in Boston.
That corresponds with big drops in breast cancer cases, but some scientists have said this could be due to a fall-off in mammograms, which would mean fewer cancers were being detected, not necessarily that fewer were occurring.
The new study puts that theory to rest. Mammography rates were virtually the same among those taking hormones and those not.
"It is clear that changing mammography patterns cannot explain the dramatic reductions in breast cancer risk," Manson said.
"The data are getting stronger," said Dr. C. Kent Osborne, a breast cancer specialist at Baylor College of Medicine in Houston.
Women who do need the pills should not panic, though the doubling of risk - a 200 percent increase - for long-term users is quite worrisome, cancer specialists say. Although the new study does not calculate risks in terms of actual cases, previous research showed that the average increased risk of 26 percent meant a difference of a few extra cases a year for every 1,000 women on hormone pills, compared with nonusers.
"Hormone therapy remains a good health care choice to relieve moderate to severe menopausal symptoms," says a statement from Wyeth, which made the pills used in the study.
"Most women should be able to discontinue hormones in three to four years," or at least reduce their dose, Manson said.
A future analysis will look at other women in the study who took only estrogen, generally women who have had hysterectomies.
© MMVIII The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.
Best-selling author Mitch Albom on his first nonfiction work since "Tuesdays with Morrie."





------------------------
Usual sexist rubbish. For better or worse Whole homone therapy started because of feminist activits. Billions have been spent on issues related to this. First to study benefits and now to study side effects
human estrogen molecule, they would not be able to patent the drug, and consequently would not make much money from it. As a result, the prescription estrogen is slightly different/patentable so the drug companies can make megabucks from it..
Posted by jntlw at 09:49 PM : Dec 13, 2008
Why is it that drug companies should be sued for producing a NATURAL chemical? Estrogen is what the doctors usually supplement for women to avoid menopause. It is a naturally produced chemical (not some drug company scheme to kill you) that was manufactured by the pharmaceutical companies because there was demand by the people to have it.
Estrogen itself is a promoter of cancer. It in itself does not cause cancer, but it makes the cells in the breast more susceptible to become mutated by a mutagen or a real cancer causing chemical.
So why don''t you stop your whining and read up on the subject. Instead of screaming SUE SUE SUE, do your own research and stop blaming "Big Pharma" for all your problems. Pharmaceutical companies are not evil. They produce products for enhancement of people''s lives, just like computer and car companies do. Just because a pill has side effects does not give you a right at all to sue for money. You should be prepared for ANY risk when you take meds, even if it is not mentioned on the bottle.
Gosh, no wonder health and medical malpractice insurances are so high. We have so many morons in this country that think it is okay to just sue for damages. Grow some balls.
My doc gave me hormones post hysterectomy [and evil hot flashes] and within a week I was having heart palpitations. I immediately stopped the hormones, learned about and used natural remedies. Black cohosh [sp], etc. I avoid pharmaceuticals totally now.
Best of luck to all the women reading this. There ARE alternatives to un-natural drugs!
- by Marie Zarankevich December 13, 2008 11:34 PM EST
- Thank Goodness SOMEBODY is finally doing CURRENT figures on some of these things everyone''s been wondering about for so long. -- It''s about darned TIME. -- We all keep assuming that medical science is up to date, and that couldn''t be farther from the truth. -- The entire field needs a HUGE amount of updating and current research, just to catch up. -- And SOON.
- Reply to this comment
See all 14 Comments